Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pfizer Inc. (PFE) Holding Dow Jones Industrial Average (.DJI) Back

Pfizer, Healthcare Hedge FundsThe Dow Jones Industrial Average (Dow Jones Indices:.DJI) is unchanged following a worse-than-expected earnings release from Pfizer Inc. (NYSE:PFE) and some mixed economic releases. As of 1:25 p.m. EDT the Dow is up just six points, while the S&P 500 is up about two points.

There were two U.S. economic releases today.

Report Period Actual Previous
Case-Shiller National Home Price Index February 0.3% 0.1%
Conference Board Consumer Confidence Index April 68.1 61.9

Source: MarketWatch U.S. Economic Calendar.

The key metric here is consumer confidence, as the Case-Shiller home price index data is for February. However, it should be noted that average home prices rose 9.3% year over year — the largest gain since 2006. Consumer confidence was expected to decline slightly to 61.3, but it surprised analysts, rising to 68.1 from March’s 61.9. Still, it’s still too early to tell how consumers are doing. The past few months have seen multiple disappointing updates on the job market, and the payroll tax hike and high gas prices are only helping to hinder the economy’s growth.

The second big piece of news today is that Pfizer Inc. (NYSE:PFE) reported earnings that missed analyst expectations. The stock is pulling down the Dow, sinking 3.4%. The pharmaceutical giant reported EPS excluding one-time items of $0.54, worse than analyst expectations of $0.56. Revenue was down 9% from last year to $13.5 billion, worse than analyst expectations of $14 billion. Pfizer Inc. (NYSE:PFE) has been hurting since Lipitor went off patent in the U.S. in 2011 and in Europe in March of last year. Lipitor used to bring in more than $10 billion in sales per year, but that has been declining quickly. In the first quarter sales were down 55% year over year to $626 million.

The main reason the stock is down, though, is that Pfizer Inc. (NYSE:PFE) lowered its earnings forecast by $0.06 to between $2.14 and $2.24 for 2013. That’s more than enough to continue funding Pfizer Inc. (NYSE:PFE)’s ample dividend of $0.24 per quarter — that’s a yield of 3.2% after today’s drop. Pfizer Inc. (NYSE:PFE) is a member of the 2013 Dogs of the Dow, as it started the year with the fifth-highest yield in the Dow.

Today’s Dow leader is American Express Company (NYSE:AXP), up 0.9%, as increased consumer confidence and rising home prices will lead to higher consumer spending than previously expected. American Express Company (NYSE:AXP) reported earnings two weeks ago that beat analyst expectations on the bottom line but missed on the top line. The company also announced a large buyback and an increase of its dividend to $0.23 per share for a yield of 1.35%. While Buffett is a large shareholder of American Express Company (NYSE:AXP), Motley Fool analyst Matt Koppenheffer thinks a different credit card company is your best bet for the next 20 years; you can read on here to find out who.

The article Pfizer Stock Is Holding Back the Dow originally appeared on and is written by Dan Dzombak.

Dan Dzombak can be found on Twitter @DanDzombak or on his Facebook page, DanDzombak. He has no position in any stocks mentioned. The Motley Fool recommends American Express.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.